GMC's guidance may inhibit research

Abstract
EDITOR—Academic clinical research, including the evaluation of new treatments, is central to providing high quality, cost effective care to patients, and it requires the cooperation and goodwill of the patients who volunteer to participate. The research process is externally regulated and monitored by ethics committees to ensure that patients are protected. We welcome the debate on the Data Protection Act and access to patients' records,1–3 and wish to raise a related concern about the General Medical Council's recent guidelines on …

This publication has 0 references indexed in Scilit: